1. Home
  2. FCT vs BNR Comparison

FCT vs BNR Comparison

Compare FCT & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust Senior Floating Rate Income Fund II of Beneficial Interest

FCT

First Trust Senior Floating Rate Income Fund II of Beneficial Interest

HOLD

Current Price

$9.44

Market Cap

250.5M

Sector

Finance

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$16.30

Market Cap

252.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCT
BNR
Founded
2004
2014
Country
United States
China
Employees
N/A
N/A
Industry
Finance Companies
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
250.5M
252.7M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
FCT
BNR
Price
$9.44
$16.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
87.4K
30.5K
Earning Date
01-01-0001
03-12-2026
Dividend Yield
11.29%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$111.65
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.25
$2.18
52 Week High
$10.29
$41.72

Technical Indicators

Market Signals
Indicator
FCT
BNR
Relative Strength Index (RSI) 32.09 36.16
Support Level $9.41 $15.52
Resistance Level $10.06 $23.42
Average True Range (ATR) 0.08 1.28
MACD -0.01 0.04
Stochastic Oscillator 9.46 7.97

Price Performance

Historical Comparison
FCT
BNR

About FCT First Trust Senior Floating Rate Income Fund II of Beneficial Interest

First Trust Senior Floating Rate Income Fund II is a United States-based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, it attempts to preserve capital. The fund invests in a portfolio of senior secured floating-rate corporate loans (Senior Loans) of companies from different industries, such as Insurance, Software, Health Care Providers and Services, Professional Services, Health Care Technology, IT Services, and others.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: